Europe — EMA
Mercaptopurina Silver (Mercaptopurine Monohydrate)
GNH USA supplies Mercaptopurina Silver (Mercaptopurine), an antimetabolite for ALL and inflammatory bowel disease.
Request sourcing
What is Mercaptopurine Monohydrate?
Mercaptopurine, the active ingredient in Mercaptopurina Silver, is an antimetabolite presented as a tablet for oral use. It is used to treat acute lymphoblastic leukemia, chronic lymphocytic leukemia, inflammatory bowel disease and other autoimmune disorders.
GNH USA supplies Mercaptopurina Silver as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Mercaptopurine Monohydrate used for?
Mercaptopurine acts on rapidly dividing cells and modulates immune function, making it useful in several hematologic and inflammatory conditions. - Acute lymphoblastic leukemia (ALL): helps achieve remission and maintain disease control. - Chronic lymphocytic leukemia (CLL): slows disease progression and supports long‑term management. - Inflammatory bowel disease (Crohn's disease, ulcerative colitis): reduces intestinal inflammation and helps maintain remission. - Autoimmune disorders (e.g., rheumatoid arthritis): suppresses abnormal immune activity.
What are the side effects of Mercaptopurine Monohydrate?
Adverse reactions may occur and should be monitored during therapy.
Common Side Effects: - Nausea and vomiting - Loss of appetite - Mild diarrhea - Transient liver enzyme elevation - Fatigue or weakness - Mild rash or itching
Serious or Rare Side Effects: - Severe bone marrow suppression (neutropenia, anemia, thrombocytopenia) - Hepatotoxicity with marked liver enzyme rise - Pancreatitis - Severe infections due to immunosuppression - Hypersensitivity reactions including Stevens‑Johnson syndrome
What precautions apply to Mercaptopurine Monohydrate?
Before initiating therapy, patients should be evaluated for baseline blood counts and liver function. - Monitor blood counts regularly: watch for neutropenia, anemia, and thrombocytopenia. - Assess liver function: check ALT, AST, and bilirubin levels. - Screen for thiopurine methyltransferase (TPMT) activity when possible to reduce toxicity risk. - Avoid use in patients with known hypersensitivity to mercaptopurine. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.
What does Mercaptopurine Monohydrate interact with?
Mercaptopurine may interact with several medicines, altering its efficacy or safety.
Major Interactions (Avoid): - Allopurinol: can increase mercaptopurine toxicity; dose adjustment required. - Azathioprine: additive myelosuppression risk. - Methotrexate: heightened bone marrow suppression.
Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Oral contraceptives: reduced effectiveness, consider alternative contraception. - Antacids containing magnesium or aluminum: may affect absorption, separate administration times.



